|
KMID : 0363620230440040041
|
|
Journal of Korean Oriental Medicine
2023 Volume.44 No. 4 p.41 ~ p.58
|
|
|
Management of asymptomatic to mild COVID-19 patients with Cheongpebaedok-tang on the telemedical basis:A retrospective observational case series
|
|
Kang Sung-Woo
Kim Kwan-Il
Song Mi-Deok
Roh Jin-Hwan
Cho Nam-Hun
Ko Heung
Son Sung-Se
Jeong Min-Jeong
Choi Jun-Yong
Kwon O-Jin
Ha Seo-Jung
Jung Hee-Jae
Lee Beom-Joon
|
|
|
Abstract
|
|
|
Objectives: This retrospective observational study aimed to investigate the efficacy and safety of Cheongpebaedok -tang, a traditional Korean herbal medicine, provided via telemedicine to patients with asymptomatic to mild COVID-19 in Korea.
Methods: From February to April 2020, a retrospective analysis investigated COVID-19 patients treated via Korean telemedicine. The study involved asymptomatic to mild cases receiving Cheongpebaedok-tang more than three times, along with continuous Korean medicine care in convalescence. Diagnoses and treatment adhered to the telemedicine guidelines of the Association of Korean Medicine, with varied Cheongpebaedok-tang prescriptions based on symptom severity. Symptom evaluation involved a detailed assessment using a 15-item tool at initial and final sessions.
Results: The study included 27 patients, with a mean age of 48.7 ± 2.3 years (mean ± standard error). Patients began self-administering oral Cheongpebaedok-tang for an average of 19.4 ± 1.8 days after the date of COVID-19 diagnosis confirmation and continued the medication for 15.8 ± 1.2 days. The reported side effects of the Cheongpebaedok-tang included palpitations (11.1%), insomnia (7.4%), dizziness (3.7%), and diarrhea (3.7%). All side effects disappeared after adjusting the prescription according to standard treatment guidelines. The occurrence of all COVID-19-related adverse symptoms, except fatigue and myalgia, decreased. Fatigue was the most common chronic symptom persisting after 6 months (51.9%), followed by ocular symptoms (37.0%) and sore throat (22.2%).
Conclusions: This study implies Cheongpebaedok-tang may offer a potentially safe, symptom-alleviating approach for managing mild COVID-19 cases via telemedicine, although further comprehensive research is warranted.
|
|
|
KEYWORD
|
|
|
COVID-19, Herbal medicine, Korean traditional medicine, Retrospective studies, Qingfei Paidu, Cheongpebaedok-tang
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|